AZN logo

AZN

AstraZeneca PLC

$91.00
+$2.32(+2.62%)
80
Overall
70
Value
91
Tech
--
Quality
Market Cap
$276.57B
Volume
7.40M
52W Range
$61.24 - $90.27
Target Price
$89.96

Latest News for AZN

Capital Group Increases Stake in AstraZeneca
TipRanks Sweden Auto-Generated Newsdesk6 days agoNov 17, 2025

An announcement from AstraZeneca ( ($GB:AZN) ) is now available. The Capital Group Companies, Inc. has increased its voting rights in AstraZeneca P......

AstraZeneca (AZN) Gets a Hold from DZ BANK AG
TipRanks Auto-Generated Intelligence Newsdesk13 days agoNov 11, 2025

In a report released yesterday, Elmar Kraus from DZ BANK AG maintained a Hold rating on AstraZeneca. The company’s shares closed yesterday at p13,1......

IonQ Secures DARPA Stage B Slot, Maps Quantum Road to 2033
Ran Melamed14 days agoNov 10, 2025

IonQ ($IONQ) has been chosen for Stage B of a major U.S. defense project that sets out to measure and define progress in quantum computing. The ini......

J.P. Morgan Reaffirms Their Buy Rating on AstraZeneca (AZN)
TipRanks Auto-Generated Intelligence Newsdesk14 days agoNov 10, 2025

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on AstraZeneca, with a price target of £140.00. Vosser covers t......

IonQ and D-Wave Q3 Earnings Results Set the Pace Ahead of Rigetti and Quantum Computing Inc.
Ran Melamed14 days agoNov 09, 2025

The latest quarterly reports from IonQ ($IONQ) and D-Wave Quantum ($QBTS) gave investors a clear read on the quantum sector’s direction. Both compa......

AstraZeneca (AZN) Gets a Buy from Goldman Sachs
TipRanks Auto-Generated Intelligence Newsdesk16 days agoNov 07, 2025

In a report released today, Rajan Sharma from Goldman Sachs maintained a Buy rating on AstraZeneca, with a price target of £155.04. According to Ti......

Shore Capital Reaffirms Their Buy Rating on AstraZeneca (AZN)
TipRanks Auto-Generated Intelligence Newsdesk17 days agoNov 06, 2025

Shore Capital analyst reiterated a Buy rating on AstraZeneca today and set a price target of p14,500.00. In addition to Shore Capital, AstraZeneca ......

AstraZeneca’s Diabetes Study: Promising Results for FDC Regimen
TipRanks Clinical-Trials-Auto-Generated Newsdesk23 days agoOct 31, 2025

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s recent clinical study, officially titled ‘E......

AstraZeneca’s New Study on Chronic Kidney Disease: Potential Market Impact
TipRanks Clinical-Trials-Auto-Generated Newsdesk24 days agoOct 30, 2025

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca is conducting a Phase IIb study titled A Phas......

AstraZeneca’s New Phase I Study on AZD0292: Key Insights for Investors
TipRanks Clinical-Trials-Auto-Generated Newsdesk25 days agoOct 29, 2025

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. AstraZeneca has initiated a Phase I clinical study titled ‘A Phase I, Ran......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 16 articles.

ABCD
1SymbolPriceChangeVol
2AZN$91.00+2.6%7.40M
3
4
5
6

Get AstraZeneca PLC Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.